trial
as of 2026-07-01Therapeutic Efficacy of Transcranial Magnetic Stimulation in Schizophrenia
NCTId NCT01551979
at a glance
— · Completed
Enrollment 22 (actual)
Sponsored by Beth Israel Deaconess Medical Center
Primary completion 2015-11
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
22 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Triple
Start
2012-02
Primary completion
2015-11
Eligibility
ALL · 18 Years · 65 Years
Interventions & indications
Sponsors
Beth Israel Deaconess Medical CenterLead Sponsor
Sidney R. Baer, Jr. FoundationCollaborator
Investigators
1
Mark A Frye, M.D.Principal Investigator
Sites
1 total
Boston, United States
Facts & assertions
4 sourced
Enrollment
22
Phase
NA
Primary Completion Date
2015-11
Status
COMPLETED
relationships
The graph out of here
lead_sponsor
collaborator
indication
indication
indication
investigator
person